Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Whether dissociation and depression are distinct constructs remains controversial. The aim of this study was to explore the interrelations and associated factors between them.

Methods: This study included inpatients with major depressive disorder (MDD) and bipolar disorder with major depressive episode (BD). Clinical rating scales were used to measure levels of depression, dissociation, and psychotic symptoms. Generalized estimating equations were used to estimate interrelations between dissociation and related factors over time, including depression. Moreover, the impacts of individual items of the Hamilton Depression Rating Scale (HAMD) on dissociation were evaluated after multiple adjustments.

Results: A total of 91 participants were included into the analysis, of whom 59 had MDD and 32 had BD. After standardized treatment, levels of depression and psychotic symptoms significantly decreased, whereas the level of dissociation did not. However, the level of dissociation significantly decreased in the high-dissociation group, and this was positively associated with the change in depression and psychotic symptoms. Female sex and comorbidity with borderline personality disorder were also positively correlated with dissociation. Among items of the HAMD, insomnia and gastrointestinal symptoms contributed to the association between depression and dissociation.

Conclusion: We identified a decoupled but intertwined relationship between dissociation and depression. Clinicians should be aware of this comorbidity and provide timely interventions for dissociation during clinical practice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12104755PMC
http://dx.doi.org/10.30773/pi.2024.0076DOI Listing

Publication Analysis

Top Keywords

dissociation depression
12
psychotic symptoms
12
dissociation
10
depression
9
decoupled intertwined
8
gastrointestinal symptoms
8
major depressive
8
levels depression
8
depression psychotic
8
level dissociation
8

Similar Publications

Objective: The objective of this study was to comprehensively examine the real-world safety of esketamine using 58 months of postapproval data in the United States.

Methods: U.S.

View Article and Find Full Text PDF

Introduction: Intranasal Esketamine is an effective rapid-acting antidepressant currently used to treat treatment-resistant depression. Artificial intelligence is another emerging tool in medicine, but little is known about the effectiveness of combining these innovations in psychiatry.

Methods: This case report presents the outcome of a 37-year-old patient who received intranasal Esketamine treatment (84 mg) and utilized artificial intelligence (ChatGPT-4) to generate images and interpretations of his experiences with dissociation.

View Article and Find Full Text PDF

Background: Although vaccination has significantly contributed to controlling the coronavirus disease 2019 (COVID-19) infections, a high risk of side effects has resulted in vaccination hesitancy. Nevertheless, as COVID-19 has become common but still has a severe impact on vulnerable people, we might need to follow a long-term vaccination routine. Therefore, elucidating the characteristics of individuals who may exhibit either vulnerability or resilience to the side effects associated with COVID-19 vaccinations is of the utmost importance for the vaccination plan against COVID-19.

View Article and Find Full Text PDF

Altered neural reward activation predicts clinical depression improvement after a novel loving-kindness meditation: a multimodal neuroimaging study.

Psychiatry Res Neuroimaging

August 2025

Department of pain, the Southwest hospital, Army Medical University, Chongqing 400038, China; College of General Education and International, Chongqing Polytechnic University of Electronic Technology, Chongqing 401331, China. Electronic address:

Objective: Major depressive disorder (MDD) has become the second largest risk factor affecting human health, with a progress in its treatment especially non-pharmacological therapies. The loving-kindness meditation (LKM) has been introduced to depression but is not popular due to requirement on awareness and concentration, and its utilization in clinical MDD is absent as well as exploration on neural mechanism. This study aims to develop a more feasible novel therapy-loving-kindness meditation integrating cognition and behavior (LKM-CB), examine its effect on clinical depression, and further explore its neural mechanism by multimodal neuroimaging.

View Article and Find Full Text PDF